Arkolith/Insider Trading/AKTX/Form 4/A

Gaslightwala Abizer

DirectorAkari Therapeutics Plc (AKTX) · full profile →Form 4/A · filed Feb 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 10, 2025Grant(A)12K$1.22$14K48K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000950170-25-016334) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML